Synergic anti-tumor effects of photodynamic therapy and resveratrol on triple-negative breast cancer cells. (2025)

Peer-Reviewed Study · Ghazizadeh M; Khorsandi K; Najafi SA · March 17, 2025

Ghazizadeh M et al., 2025-03-17: Triple-negative breast cancer (MDA-MB-231) cell study finding methylene blue photodynamic therapy plus resveratrol killed more cells than either alone.

The findings indicated that the co-administration of MB-PDT and RES resulted in increased cytotoxic effects on MDA-MB-231 breast cancer cells compared to the individual application of either treatment.

Ghazizadeh M et al., 2025-03-17: Triple-negative breast cancer (MDA-MB-231) cell study finding methylene blue photodynamic therapy plus resveratrol killed more cells than either alone. C3 Ghazizadeh 2025. Study type: in vitro cell-line study (MDA-MB-231 triple-negative breast cancer). Country: Iran (Islamic Azad University, Tehran, per author affiliations as indexed). Dose: 'different methylene blue doses' with laser irradiation – exact uM values not in the abstract text captured; resveratrol concentrations varied. Light required: yes, laser irradiation is the PDT arm. Funder: not stated in the record. Conflicts: 'The authors declare that they have no conflict of interest.' Comparator: MB-PDT alone, resveratrol alone, untreated cells. Reports synergy, not an absolute kill rate. Study type: lab.